Germany's Hidden Crisis: How COVID Left Thousands with Lifelong Illnesses

Six years ago, Germany confirmed its first coronavirus case in North Rhine-Westphalia. Since then, the country has recorded around 40 million infections. Many of those affected still face long-term health struggles, including conditions like ME/CFS—a severe and often misunderstood illness.

Philipp Damerau, now 20, was just 14 when a suspected COVID-19 infection left him with extreme fatigue, muscle pain, and cognitive difficulties. Doctors later diagnosed him with ME/CFS, a debilitating condition that disrupts the immune system, nervous system, and energy production. His symptoms include post-exertional malaise, where even minor physical or mental effort triggers severe relapses.

ME/CFS remains hard to diagnose due to the lack of specific lab tests or biomarkers. Many patients face misdiagnoses or delays in treatment. In Germany, over 620,000 people were estimated to have ME/CFS in 2023, with numbers likely higher than reported. Social insurance data often misses cases, and experts expect the figure to grow as more long-COVID patients develop the condition.

Studies suggest at least 6.5% of non-hospitalised COVID-19 patients develop Post-COVID symptoms within 6-12 months. While some improve over time, others, like Damerau, see only slight progress. His life remains drastically changed, though he holds hope for future research breakthroughs.

There is no approved cure for ME/CFS. Treatment focuses on managing symptoms and conserving energy through pacing. Long COVID, Post-COVID, and ME/CFS are distinct but overlapping conditions, each with varying symptoms and durations. Over a million Germans still suffer from persistent COVID-19 effects, highlighting the pandemic's lasting impact.

ME/CFS continues to affect hundreds of thousands in Germany, with many cases going undiagnosed or underreported. Patients like Damerau rely on symptom management while waiting for better treatments. The condition's long-term effects underscore the need for further research and medical support.